BioCryst to Present at Upcoming Investor Conferences
Tuesday, April 28, 2026 1 min read
Key Takeaway: BioCryst Pharmaceuticals announced its participation in two upcoming investor conferences. The Bank of America Health Care Conference will take place on May 12, 2026, followed by the Jefferies Global Healthcare Conference on June 3, 2026. These events will allow the company to present its advancements in rare disease treatments.
Conference Participation Details
Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
Archived versions will be available following the live events for a limited time.
Market Sentiment Analysis
POSITIVE FACTORS
BioCryst is actively engaging with investors through presentations.
The company is showcasing its commitment to rare disease treatment.
Upcoming conferences provide a platform for sharing advancements.
Full Press Release Details
RESEARCH TRIANGLE PARK, N.C., April 28, 2026 (GLOBE NEWSWIRE) --BioCryst Pharmaceuticals, Inc.(Nasdaq: BCRX) today announced that the company plans to present at the following conferences:
• Bank of America Health Care Conference in Las Vegas on Tuesday, May 12, 2026, at 4:40 p.m. ET.
• Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026, at 3:45 p.m. ET.
Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website atwww.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO®(berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visitwww.biocryst.comor follow us onLinkedIn.